NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/17/2020
Back to search
Official data from USPTO
TRIPHASE PHARMA SOLUTIONS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TRIPHASE PHARMA SOLUTIONS
ST13
US500000077964084Class
35, 42
Filing
77964084
Registration
3935694
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
08/17/2020
Trademark type
Word
Nice classes
35, 42
Filing date
03/20/2010
Registration date
03/22/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/17/2020
Last transaction
08/17/2020
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/01/2010
First use in commerce
11/01/2010
Drawing code
4
Owner type
16
Owner location
Raleigh, NC
Examiner
RUTLAND, BARBARA A
Law office
L10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
TRIPHASE Pharma Solutions, LLC
Representatives
TRIPHASE Pharma Solutions, LLC
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business management and consulting services for the health care industrycustomer serviceaccounting servicesmarketing services; Business management and consulting services for the health care industryproviding industry expertise and supplier partnerships; Consulting services in the field of medical product approval for commercial purposes; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Providing technical consulting services and information management servicesclinical data and regulatory submission management to medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval
Class 42
Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; Consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development and consultation related thereto in the field of drug development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Scientific consulting and research services relating to foods and dietary supplements
Publications
History of USPTO decisions and trademark events.
47 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/17/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/17/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/17/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
06/28/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/22/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/03/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/03/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/03/2016
E815
TEAS SECTION 8 & 15 RECEIVED
03/23/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/23/2016
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/22/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
03/22/2011
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/17/2011
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
02/16/2011
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/11/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/31/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/31/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/20/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/20/2011
GNRT
NON-FINAL ACTION E-MAILED
01/20/2011
CNRT
SU - NON-FINAL ACTION - WRITTEN
01/20/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/14/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/14/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/10/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/09/2010
GNRT
NON-FINAL ACTION E-MAILED
12/09/2010
CNRT
SU - NON-FINAL ACTION - WRITTEN
12/09/2010
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/18/2010
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/18/2010
IUAF
USE AMENDMENT FILED
11/04/2010
EISU
TEAS STATEMENT OF USE RECEIVED
11/04/2010
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/02/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/07/2010
PUBO
PUBLISHED FOR OPPOSITION
09/07/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/04/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/03/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/20/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/20/2010
ALIE
ASSIGNED TO LIE
07/20/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/07/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/29/2010
GNRT
NON-FINAL ACTION E-MAILED
06/29/2010
CNRT
NON-FINAL ACTION WRITTEN
06/29/2010
DOCK
ASSIGNED TO EXAMINER
06/21/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/25/2010
NWAP
NEW APPLICATION ENTERED
03/24/2010
Continuous trademark protection
Get notified about every new filing that threatens TRIPHASE PHARMA SOLUTIONS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.